Cara Mooney
BSc (Hons), MSc
Population Health, School of Medicine and Population Health
Research Fellow / Senior Trial Manager
CTRU Lead Trial Manager
+44 114 222 4308
Full contact details
Population Health, School of Medicine and Population Health
The Innovation Centre
217 Portobello
Sheffield
S1 4DP
- Profile
-
I am a Research Fellow and Senior Trial Manager in the CTRU interested in trial methodology and implementation, I am particularly interested in Health behaviour change interventions and retention of participants.
I joined the University of Sheffield in 2013 as a research assistant in the Clinical Trials Research Unit working on the PLEASANT trial and assisting on the Healthlines study. I am currently the trial manager for the Orion project. I have previously been trial manager for the Multiple Symptoms Study 3, the TRICEPS trial, MERIDIAN studies and STOP-OHSS. I am also a co-applicant on the RHABIT methodological project and Stratcare-2.
Prior to joining the University, I worked on a health promotion programme within Rotherham NHS Maternity Service. I have also done voluntary work on a number of weight management programmes, which involved carrying out health assessments and delivering nutrition and lifestyle advice.
I became Lead Trial Manager in 2021, providing support for study management staff including providing advice on implementation and co-ordinating and developing training development and staff inductions. I am also a member of the CTRU Management Group.
- Qualifications
-
- BSc (Hons) Nutrition, Health and Lifestyle
- MSc Physical Activity for Health
- Research interests
-
- Health behaviour change interventions
- Recruitment to trials
- Retention of trial participants
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- Post-mortem confirmation of fetal brain abnormalities: challenges highlighted by the MERIDIAN cohort study. BJOG: An International Journal of Obstetrics and Gynaecology. View this article in WRRO
- Accuracy of in-utero MRI to detect fetal brain abnormalities and prognosticate developmental outcome: Postnatal follow-up of the MERIDIAN cohort. The Lancet Child and Adolescent Health. View this article in WRRO
- MRI in the diagnosis of fetal developmental brain abnormalities : the MERIDIAN diagnostic accuracy study. Health Technology Assessment, 23(49), 1-144. View this article in WRRO
- The rate of brain abnormalities on in utero MRI studies in fetuses with normal ultrasound examinations of the brain and calculation of indicators of diagnostic performance. Clinical Radiology, 74(7), 527-533. View this article in WRRO
- An integrated in utero MR method for assessing structural brain abnormalities and measuring intracranial volumes in fetuses with congenital heart disease: results of a prospective case-control feasibility study. Neuroradiology. View this article in WRRO
- Anatomical subgroup analysis of the MERIDIAN cohort: Ventriculomegaly. Ultrasound in Obstetrics & Gynecology, 50(6), 736-744. View this article in WRRO
- Change in diagnostic confidence brought about by using in utero MRI for fetal structural brain pathology: analysis of the MERIDIAN cohort.. Clinical radiology, 72(6), 451-457. View this article in WRRO
- A systematic review and meta-analysis to determine the contribution of mr imaging to the diagnosis of foetal brain abnormalities In Utero. European Radiology, 27(6), 2367-2380. View this article in WRRO
- Anatomical subgroup analysis of the MERIDIAN cohort: failed commissuration. Ultrasound in Obstetrics & Gynecology. View this article in WRRO
- Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre, prospective cohort study. The Lancet, 389(10068), 538-546. View this article in WRRO
- Preventing and Lessening Exacerbations of Asthma in School-aged children Associated with a New Term (PLEASANT): Recruiting Primary Care Research Sites–the PLEASANT experience. npj Primary Care Respiratory Medicine, 25(1). View this article in WRRO
All publications
Journal articles
- Effectiveness of a symptom-clinic intervention delivered by general practitioners with an extended role for people with multiple and persistent physical symptoms in England: the Multiple Symptoms Study 3 pragmatic, multicentre, parallel-group, individually randomised controlled trial. The Lancet, 403(10444), 2619-2629. View this article in WRRO
- Explanation for symptoms and biographical repair in a clinic for persistent physical symptoms. SSM - Qualitative Research in Health, 100438-100438.
- Recording harms in randomised controlled trials of behaviour change interventions: a qualitative study of UK clinical trials units and NIHR trial investigators. Trials, 25. View this article in WRRO
- Recording harms in randomized controlled trials of behavior change interventions: a scoping review and map of the evidence. Journal of Clinical Epidemiology, 169, 111275-111275.
- Outpatient paracentesis for the management of ovarian hyperstimulation syndrome: study protocol for the STOP-OHSS randomised controlled trial. BMJ Open, 14(1), e076434-e076434.
- SWAT 137: A 2x2 randomised factorial SWAT of the use of a pen and brief information leaflet to improve recruitment in a randomised controlled trial of a community-based clinic for patients with persistent physical symptoms [version 1; peer review: awaiting peer review]. F1000Research, 12. View this article in WRRO
- Recognition, explanation, action, learning: teaching and delivery of a consultation model for persistent physical symptoms.. Patient Education and Counseling, 115. View this article in WRRO
- Sex differences in fetal intracranial volumes assessed by in utero MR imaging. Biology of Sex Differences, 14(1).
- Study protocol for the Multiple Symptoms Study 3: a pragmatic, randomised controlled trial of a clinic for patients with persistent (medically unexplained) physical symptoms. BMJ Open, 12(11).
- Adverse event recording failed to reflect potential harms: A review of trial protocols of behavioural, lifestyle and psychological therapy interventions.. Journal of Clinical Epidemiology.
- Post-mortem confirmation of fetal brain abnormalities: challenges highlighted by the MERIDIAN cohort study. BJOG: An International Journal of Obstetrics and Gynaecology. View this article in WRRO
- Accuracy of in-utero MRI to detect fetal brain abnormalities and prognosticate developmental outcome: Postnatal follow-up of the MERIDIAN cohort. The Lancet Child and Adolescent Health. View this article in WRRO
- MRI in the diagnosis of fetal developmental brain abnormalities : the MERIDIAN diagnostic accuracy study. Health Technology Assessment, 23(49), 1-144. View this article in WRRO
- The rate of brain abnormalities on in utero MRI studies in fetuses with normal ultrasound examinations of the brain and calculation of indicators of diagnostic performance. Clinical Radiology, 74(7), 527-533. View this article in WRRO
- An integrated in utero MR method for assessing structural brain abnormalities and measuring intracranial volumes in fetuses with congenital heart disease: results of a prospective case-control feasibility study. Neuroradiology. View this article in WRRO
- A Review of Fetal Brain Pathology Acquired In Utero. Neurographics, 9(1), 79-89. View this article in WRRO
- Analysis of errors made on in utero MR studies of the fetal brain in the MERIDIAN study. European Radiology, 29(1), 195-201. View this article in WRRO
- Should we perform in utero MRI on a fetus at increased risk of a brain abnormality if ultrasonography is normal or shows non-specific findings?. Clinical Radiology, 73(2), 123-134. View this article in WRRO
- Anatomical subgroup analysis of the MERIDIAN cohort: Ventriculomegaly. Ultrasound in Obstetrics & Gynecology, 50(6), 736-744. View this article in WRRO
- Anatomical subgroup analysis of the MERIDIAN cohort: posterior fossa abnormalities. Ultrasound in Obstetrics and Gynecology, 50(6), 745-752. View this article in WRRO
- Change in diagnostic confidence brought about by using in utero MRI for fetal structural brain pathology: analysis of the MERIDIAN cohort.. Clinical radiology, 72(6), 451-457. View this article in WRRO
- A systematic review and meta-analysis to determine the contribution of mr imaging to the diagnosis of foetal brain abnormalities In Utero. European Radiology, 27(6), 2367-2380. View this article in WRRO
- Use of MRI in the Diagnosis of Fetal Brain Abnormalities in Utero (MERIDIAN). Obstetrical & Gynecological Survey, 72(6), 323-325.
- Anatomical subgroup analysis of the MERIDIAN cohort: failed commissuration. Ultrasound in Obstetrics & Gynecology. View this article in WRRO
- Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre, prospective cohort study. The Lancet, 389(10068), 538-546. View this article in WRRO
- Preventing and Lessening Exacerbations of Asthma in School-aged children Associated with a New Term (PLEASANT): Recruiting Primary Care Research Sites–the PLEASANT experience. npj Primary Care Respiratory Medicine, 25(1). View this article in WRRO
- Recommendations on recording harms in randomised controlled trials of behaviour change interventions. BMJ, e077418-e077418.
- Correction: Sex differences in fetal intracranial volumes assessed by in utero MR imaging. Biology of Sex Differences, 14(1).
- Predicting neurodevelopmental outcomes in fetuses with isolated mild ventriculomegaly. Archives of Disease in Childhood - Fetal and Neonatal Edition.
- Variation in prognosis given by fetomaternal units in fetuses with neurological abnormalities. Archives of Disease in Childhood - Fetal and Neonatal Edition. View this article in WRRO
Conference proceedings papers
- Research group
-
- EXPERTS-ALS: EXPErimental medicine Route To Success in Amyotrophic Lateral Sclerosis
- ORION: RadiO fRequency ablatION for haemorrhoids
- MSS3: Multilple Symptoms Study 3
- MERIDIAN: Magnetic Resonance Imaging to Enhance the Diagnosis of Fetal Developmental Brain Abnormalities in Utero
- MERIDIAN 2-3 year follow up study
- TRICEPS : Transcutaneous Vagus Nerve Stimulation Post-Stroke
- RHABIT: Recording Harms in Behavioural change intervention Trials
- Teaching activities
-
I am involved in delivering various aspects of Master level programs at ScHARR including:
- Supervising and marking dissertations on the Masters in Human Nutrition, Masters in Public Health, and Masters in Clinical Research
- Seminar tutor on the Masters in Human Nutrition and Masters in Clinical Research Dissertation module
- Deputy module leader on Randomised Controlled Trials to Support Reimbursement Decision Making (online) module
- Personal tutor to Masters Level students
- Professional activities and memberships
-
I am a member of the ScHARR Ethics Committee. I am also a member of the UKCRC Monitoring Task and Finish Group.